GSK1070916A
Term · Oncology and biomedicine · MLC-T-ONC-003681
A substance being studied in the treatment of some types of cancer. It blocks certain enzymes (Aurora kinases) involved in cell division and may kill cancer cells. It is a type of serine/threonine protein kinase inhibitor. Also called Aurora B/C kinase inhibitor GSK1070916A.
| Identifier | MLC-T-ONC-003681 |
|---|---|
| Field | Oncology and biomedicine |
| Expansions | Aurora B/C kinase inhibitor GSK1070916A |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-003681",
"term": "GSK1070916A",
"field": "Oncology and biomedicine",
"definition": "A substance being studied in the treatment of some types of cancer. It blocks certain enzymes (Aurora kinases) involved in cell division and may kill cancer cells. It is a type of serine/threonine protein kinase inhibitor. Also called Aurora B/C kinase inhibitor GSK1070916A.",
"expansions": [
"Aurora B/C kinase inhibitor GSK1070916A"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/gsk1070916a/"
}
Record 8,210 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.